At RheumaFinder, we are constantly seeking innovative solutions to improve the detection and treatment of rheumatic diseases. Recently, we posed a thought-provoking question:
What if we could detect rheumatic diseases up to 10 years before a diagnosis is made?
This question guided the discussions at our successful investor event held at the Orsi Academy in Melle on 17 December 2024.
Approximately 40 attendees, including radiologists, rheumatologists, and entrepreneurs, gathered to hear the latest updates regarding RheumaFinder’s clinical, product, and business developments. We are thrilled to report that several participants took the initiative to invest, expanding our support base and securing the future of our company.
We proudly announce that we have successfully closed this investment round, achieving a 100% target! After 20 years of research in the field, our latest AI deep learning technology enables us to tackle the unmet need for accurate detection of rheumatic diseases.
The insights and contributions from our investors will help us continue to innovate and redefine the future of rheumatology. Stay tuned for more exciting updates from RheumaFinder as we work towards transforming healthcare through advanced technology.
Follow us on LinkedIn for the latest updates!